ReviewJournal of clinical medicine2023
Review of Diagnostic Modalities for Adrenal Incidentaloma.
Review in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Adrenal lesions in young adults: variability in radiology reporting and implications for clinical evaluation.Abdominal radiology (New York) · 2026Article
- Radiomic Characterization of Adrenal Incidentalomas on NECT: Retrospective Exploratory Study and Systematic Review.Journal of imaging · 2026Article
- Glucocorticoid and mineralocorticoid production in hormonally silent adrenocortical tumor tissue in dogs.Journal of veterinary internal medicine · 2026Article
- Retroperitoneal bronchogenic cyst masquerading as an adrenal incidentaloma.Endocrinology, diabetes & metabolism case reports · 2025Article
- Who and how to screen for endogenous hypercortisolism in adrenal and pituitary incidentaloma.Journal of endocrinological investigation · 2025Review
- Primary adrenal lymphoma and its mimics: clinico-radiological differential diagnosis.Frontiers in endocrinology · 2025Article
- Multi-model radiomics and machine learning for differentiating lipid-poor adrenal adenomas from metastases using automatic segmentation.Frontiers in oncology · 2025Article
- Adrenal Pseudocyst Masquerading as Adrenocortical Carcinoma.Clinical medicine insights. Endocrinology and diabetes · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adrenal incidentalomas are common findings in clinical practice, with a prevalence of up to 4.2% in radiological studies. Due to the large number of focal lesions in the adrenal glands, it can be challenging to make a definitive diagnosis and determine the appropriate management. The purpose of this review is to present current diagnostic modalities used to preoperatively distinguish between adrenocortical adenoma (ACA) and adrenocortical cancer (ACC). Proper management and diagnosis are crucial in avoiding unnecessary adrenalectomies, which occur in over 40% of cases. A literature analysis was conducted to compare ACA and ACC using imaging studies, hormonal evaluation, pathological workup, and liquid biopsy. Before deciding on surgical treatment, the nature of the tumor can be accurately determined using noncontrast CT imaging combined with tumor size and metabolomics. This approach helps to narrow down the group of patients with adrenal tumors who require surgical treatment due to the suspected malignant nature of the lesion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.